SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing strong upward momentum as investors pivot toward its QNX division's role in the growing physical AI and robotics sectors, with community sentiment fueled by bullish sentiment regarding new federal certifications and institutional buying. The stock is currently trending on the back of massive volume and excitement surrounding upcoming robotics conference presentations, as shareholders express high conviction in the company's long-term software pivot.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler stock is experiencing a sharp sell-off following a guidance update that revealed a projected deceleration in revenue growth, overshadowing a solid earnings beat. Community sentiment is deeply divided as investors debate whether the 30% drop is a major buying opportunity for a long-term AI cybersecurity leader or a structural reassessment of the company's growth trajectory and sales execution.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is currently a focal point for the market as investors wait for its upcoming earnings report, which is being viewed as a critical "redemption test" for the enterprise software sector. The community is actively debating whether Salesforce can successfully monetize its AI initiatives to prove it remains a growth leader, with many retail investors hoping for a major rebound after a challenging start to the year.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant momentum as investors anticipate upcoming satellite launches and react to Europes push to favor regional satellite operators over competitors. The community remains highly active, debating the stock's long-term valuation versus its rapid price appreciation, with heavy institutional buying fueling speculation of a potential short squeeze.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is experiencing significant volatility driven by community-driven expectations of a potential short squeeze, fueled by high short interest and a shrinking float from share buybacks. Traders are actively discussing the stock's AI-focused restructuring and technical indicators, drawing parallels to past parabolic squeeze setups and monitoring call option open interest for signs of forced dealer hedging.

Digital Turbine, Inc. is a mobile growth platform that offers solutions for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The firm operates through the On Device Solutions (ODS) and App Growth Platform (AGP) segments. The ODS segment generates revenue from the delivery of mobile application media or content to end users with solutions for all participants in the mobile application ecosystem that want to connect with end users and consumers who hold the device. This includes mobile carriers and device OEMs that participate in the app economy, app publishers and developers, and brands and advertising agencies. The AGP segment provides platforms that allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbine is experiencing a significant surge in volume and price momentum following a strong quarterly performance and optimistic fiscal guidance that beat market expectations. Investors are actively debating the potential for a sustained breakout versus historical patterns of volatility, while many are focused on whether recent AI-focused partnerships can successfully re-rate the stock's valuation.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to massive sector-wide volatility and speculative momentum following a federal announcement of billions in funding for quantum computing infrastructure. While the broader community is divided between bullish excitement over government validation of quantum technologies and bearish warnings about extreme valuations and speculative excess, active discourse remains heavily focused on potential short squeezes and high-volume institutional interest.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing heightened investor interest and upward momentum driven by strong institutional backing and a major stake acquisition by AMD, highlighting its critical role in AI infrastructure. The community is actively debating the stock's valuation, weighing its rapid ascent against potential long-term benefits of the AI networking and custom silicon buildout as earnings approach.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific stock is facing significant downward pressure as investors react to a downward revision in full-year guidance and concerns over competitive dynamics within the electrophysiology sector. While some market participants are calling the steep pullback an overreaction and eyeing entry points, community discourse remains split between those positioning for a long-term rebound and others bracing for further volatility following the guidance cut.

Sidus Space, Inc. is a space-as-a-service company. The firm focuses on commercial satellite design, manufacture, launch planning, mission operations and in-orbit support, and data collection with a vision to demonstrate space operations for new technologies, and deliver data and predictive analytics to both domestic and global customers. The company was founded by Carol M. Craig on July 17, 2012 and is headquartered in Merritt Island, FL.

Sidus Space Inc - Ordinary Shares - Class A

Sidus Space is trending as investors capitalize on surging interest in the aerospace and satellite infrastructure sector, fueled by recent revenue growth and anticipation surrounding a major upcoming space industry IPO. The community is actively debating potential momentum-driven price swings, with many highlighting its inclusion in the Russell 3000 as a key catalyst for institutional interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurocrine Biosciences to Present at Upcoming Investor Conferences in June

Neurocrine Biosciences to Present at Upcoming Investor Conferences in June Neurocrine Biosciences to Present at Upcoming Investor Conferences in June PR Newswire SAN DIEGO, May 26, 2026 SAN DIEGO, May 26, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its...

Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA (valbenazine) Capsules

Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA (valbenazine) Capsules Neurocrine Biosciences Presents...

Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics

Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics PR Newswire SAN DIEGO, May 18, 2026 Strengthens Neurocrine's...

Xenon Q1 Earnings Match Estimates, Pipeline Development in Focus

XENE's Q1 loss matches estimates, while phase III azetukalner data, cash growth and late-stage pipeline progress stay in focus.

Neurocrine (NBIX) is an Incredible Growth Stock: 3 Reasons Why 

Neurocrine (NBIX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Citigroup Issues Positive Forecast for Neurocrine Biosciences (NASDAQ:NBIX) Stock Price

Citigroup upped their price objective on Neurocrine Biosciences from $242.00 to $246.00 and gave the stock a "buy" rating in a research report on Wednesday...

Morgan Stanley Forecasts Strong Price Appreciation for Neurocrine Biosciences (NASDAQ:NBIX) Stock

Morgan Stanley upped their price objective on shares of Neurocrine Biosciences from $185.00 to $191.00 and gave the company an "equal weight" rating in a research note on Wednesday...

Royal Bank Of Canada Issues Positive Forecast for Neurocrine Biosciences (NASDAQ:NBIX) Stock Price

Royal Bank Of Canada raised their target price on shares of Neurocrine Biosciences from $176.00 to $180.00 and gave the stock an "outperform" rating in a research report on Wednesday...

Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Expected to Rise, Piper Sandler Analyst Says

Piper Sandler raised their target price on Neurocrine Biosciences from $190.00 to $207.00 and gave the company an "overweight" rating in a report on Wednesday...

Neurocrine Biosciences' (NBIX) Buy Rating Reiterated at Guggenheim

Guggenheim reiterated a "buy" rating and set a $175.00 price target on shares of Neurocrine Biosciences in a research report on Wednesday...

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.57	--	--	N/A
Q1 '26	$1.22	$1.91	57.05%	BEAT
Q4 '25	$1.80	$1.48	-17.97%	MISSED
Q3 '25	$1.59	$2.04	28.53%	BEAT
Q2 '25	$0.96	$1.06	9.89%	BEAT

NBIX
Neurocrine Biosciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest NBIX News

NBIXNeurocrine Biosciences, Inc.